RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 133 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,481 | -37.1% | 80,455 | -38.6% | 0.00% | -33.3% |
| Q2 2023 | $978,794 | +76249.0% | 131,030 | -31.8% | 0.00% | -25.0% |
| Q1 2023 | $1,282 | -16.3% | 192,156 | -3.3% | 0.00% | -20.0% |
| Q4 2022 | $1,532 | -99.9% | 198,725 | -0.4% | 0.01% | -37.5% |
| Q3 2022 | $2,123,000 | +49.4% | 199,488 | +14.3% | 0.01% | +33.3% |
| Q2 2022 | $1,421,000 | +607.0% | 174,537 | +520.7% | 0.01% | +500.0% |
| Q1 2022 | $201,000 | – | 28,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $16,889,000 | 37.30% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $31,958,000 | 5.87% |
| Yong Rong (HK) Asset Management Ltd | 377,000 | $8,675,000 | 5.69% |
| Samsara BioCapital, LLC | 752,939 | $17,325,000 | 2.72% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $34,728,000 | 2.04% |
| Spouting Rock Asset Management, LLC | 52,851 | $1,216,000 | 0.61% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 661,703 | $15,226,000 | 0.43% |
| Laurion Capital Management LP | 3,923,713 | $90,285,000 | 0.38% |
| Casdin Capital, LLC | 548,156 | $12,613,000 | 0.31% |
| Baillie Gifford | 22,061,374 | $507,632,000 | 0.27% |